Literature DB >> 8079811

Calcium overload toxicity and functional impairment in peritoneal leukocytes elicited by glycogen or interleukin-1 beta.

K Charalambous1, B de las Heras, J R Hoult.   

Abstract

Although calcium plays an important role in the activation of leukocytes for such processes as eicosanoid biosynthesis, secretion of granular constituents and superoxide generation, sustained high levels of intracellular calcium ions may be toxic. We have previously found that high concentrations of calcium ionophores induce a rapid-onset "calcium overload" toxicity in rat peritoneal leukocytes, in which functional responses such as beta-glucuronidase secretion, superoxide generation and leukotriene B4 synthesis are greatly attenuated, and some leakage of cytoplasmic LDH occurs. We have now compared this phenomenon in peritoneal leukocytes elicited from animals pretreated in three ways: glycogen, interleukin-1 beta (IL-1 beta) alone or glycogen plus IL-1 beta. Peritoneal administration of IL-1 beta caused elicitation of cells which were enriched in eosinophils; however, the functional responses of the cells in all three groups were broadly similar in terms of the ability of the agonists FMLP, PMA and A23187 to initiate superoxide generation, beta-glucuronidase secretion and leukotriene generation. Cells from all three treatment groups showed diminished responsiveness at 10(-5) M A23187, indicative of calcium overload toxicity. This was most evident for the superoxide and beta-glucuronidase responses. Some quantitative differences observed between treatment groups may reflect the different sensitivities of the various cells contained in the mixed leukocyte preparations. We conclude that IL-1 beta induces leukocyte emigration into the peritoneal cavity but that the cell population is different from that induced by glycogen. However, the cells retain susceptibility to calcium overload toxicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079811     DOI: 10.1007/bf01986406

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

Authors:  J M Schröder; U Mrowietz; E Morita; E Christophers
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

2.  Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids.

Authors:  M A Moroney; M J Alcaraz; R A Forder; F Carey; J R Hoult
Journal:  J Pharm Pharmacol       Date:  1988-11       Impact factor: 3.765

3.  Interleukin 1: a common endogenous mediator of inflammation and the local Shwartzman reaction.

Authors:  G Beck; G S Habicht; J L Benach; F Miller
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

4.  Neutrophil stimulation by recombinant cytokines and a factor produced by IL-1-treated human synovial cell cultures.

Authors:  M L Watson; G P Lewis; J Westwick
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

5.  Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes.

Authors:  T R Ulich; J del Castillo; M Keys; G A Granger; R X Ni
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

Review 6.  Determination of the primary and secondary structure of NAP-1/IL-8 and a monocyte chemoattractant protein, MCP-1/MCAF.

Authors:  E Appella; K Matsushima; J J Oppenheim; T Yoshimura; E J Leonard; G M Clore; A M Gronenborn
Journal:  Prog Clin Biol Res       Date:  1990

7.  Modulation of IL-1, tumor necrosis factor, and C5a-mediated murine neutrophil migration by alpha-melanocyte-stimulating hormone.

Authors:  M J Mason; D Van Epps
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

8.  Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis.

Authors:  D N Sauder; N L Mounessa; S I Katz; C A Dinarello; J I Gallin
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

9.  Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.

Authors:  T A Luger; J A Charon; M Colot; M Micksche; J J Oppenheim
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  A novel neutrophil-activating factor produced by human mononuclear phagocytes.

Authors:  P Peveri; A Walz; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

  10 in total
  1 in total

1.  Novel anti-inflammatory plant labdanes: comparison of in vitro properties with aspirin and indomethacin.

Authors:  B de las Heras; A Villar; J M Vivas; J R Hoult
Journal:  Agents Actions       Date:  1994-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.